| 摘要 |
The present invention is directed to the treatment of erythromelalgiacomprising administering to a subject in need thereof, a therapeutically effective amount of 5-(4- {[(2-fluorophenyl)methyl]oxy}phenyl)-prolinamideor a pharmaceutically acceptable salt, solvate or prodrug thereof. |
